Reagentless Measurement of Aminoglycoside Antibiotics in Blood Serum via an Electrochemical, Ribonucleic Acid Aptamer-Based Biosensor
- 5 August 2010
- journal article
- research article
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 82 (17), 7090-7095
- https://doi.org/10.1021/ac101491d
Abstract
Biosensors built using ribonucleic acid (RNA) aptamers show promise as tools for point-of-care medical diagnostics, but they remain vulnerable to nuclease degradation when deployed in clinical samples. To explore methods for protecting RNA-based biosensors from such degradation we have constructed and characterized an electrochemical, aptamer-based sensor for the detection of aminoglycosidic antibiotics. We find that while this sensor achieves low micromolar detection limits and subminute equilibration times when challenged in buffer, it deteriorates rapidly when immersed directly in blood serum. In order to circumvent this problem, we have developed and tested sensors employing modified versions of the same aptamer. Our first effort to this end entailed the methylation of all of the 2′-hydroxyl groups outside of the aptamer’s antibiotic binding pocket. However, while devices employing this modified aptamer are as sensitive as those employing an unmodified parent, the modification fails to confer greater stability when the sensor is challenged directly in blood serum. As a second potentially naive alternative, we replaced the RNA bases in the aptamer with their more degradation-resistant deoxyribonucleic acid (DNA) equivalents. Surprisingly and unlike control DNA-stem loops employing other sequences, this DNA aptamer retains the ability to bind aminoglycosides, albeit with poorer affinity than the parent RNA aptamer. Unfortunately, however, while sensors fabricated using this DNA aptamer are stable in blood serum, its lower affinity pushes their detection limits above the therapeutically relevant range. Finally, we find that ultrafiltration through a low-molecular-weight-cutoff spin column rapidly and efficiently removes the relevant nucleases from serum samples spiked with gentamicin, allowing the convenient detection of this aminoglycoside at clinically relevant concentrations using the original RNA-based sensor.Keywords
This publication has 28 references indexed in Scilit:
- Retention of function in the DNA homolog of the RNA dopamine aptamerBiochemical and Biophysical Research Communications, 2009
- Optimization of the Electrochemical RNA‐Aptamer Based Biosensor for Theophylline by Using a Methylene Blue Redox LabelElectroanalysis, 2009
- An Electrochemical Sensor for the Detection of Protein−Small Molecule Interactions Directly in Serum and Other Complex MatricesJournal of the American Chemical Society, 2009
- Continuous, Real-Time Monitoring of Cocaine in Undiluted Blood Serum via a Microfluidic, Electrochemical Aptamer-Based SensorJournal of the American Chemical Society, 2009
- A Target-Responsive Electrochemical Aptamer Switch (TREAS) for Reagentless Detection of Nanomolar ATPJournal of the American Chemical Society, 2007
- Aptamer-Based Electrochemical Detection of Picomolar Platelet-Derived Growth Factor Directly in Blood SerumAnalytical Chemistry, 2006
- Aptamer conformational switch as sensitive electrochemical biosensor for potassium ion recognitionChemical Communications, 2006
- The therapeutic monitoring of antimicrobial agentsBritish Journal of Clinical Pharmacology, 2001
- In Vitro Selection of Dopamine RNA LigandsBiochemistry, 1997
- Administration of Tobramycin and Gentamicin by the Intravenous Route Every 6 Hr in Patients with Normal Renal FunctionThe Journal of Infectious Diseases, 1976